Point72 Asset Management
MDCO

Point72 Asset Management’s Medicines Co MDCO Stock Holding History

Point72 Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17,600
Closed -$492K – 1647
2019
Q1 		$492K Buy
+17,600
New +$415K ﹤0.01% 869
2018
Q1 		– Sell
-35,235
Closed -$963K – 1216
2017
Q4 		$963K Buy
+35,235
New +$1.09M ﹤0.01% 807
2017
Q2 		– Sell
-80,496
Closed -$3.94M – 1079
2017
Q1 		$3.94M Buy
+80,496
New +$3.67M 0.02% 582
2016
Q4 		– Sell
-176,900
Closed -$6.68M – 911
2016
Q3 		$6.68M Sell
176,900
-83,700
-32% -$3.15M 0.05% 355
2016
Q2 		$8.76M Sell
260,600
-59,100
-18% -$2.08M 0.06% 321
2016
Q1 		$10.2M Sell
319,700
-336,800
-51% -$11M 0.08% 280
2015
Q4 		$24.5M Buy
+656,500
New +$24.8M 0.2% 134
2015
Q2 		– Sell
-273,500
Closed -$7.66M – 917
2015
Q1 		$7.66M Buy
273,500
+51,900
+23% +$1.46M 0.05% 378
2014
Q4 		$6.13M Buy
+221,600
New +$5.49M 0.04% 403

Other funds holding MDCO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Point72 Asset Management's MDCO Position: Q2 2019 in Review

Point72 Asset Management sold out of Medicines Co (MDCO) in Q2 2019, closing a stake of 17,600 shares — an estimated $492K sold.

Point72 Asset Management first reported a position in MDCO in Q4 2014 and held it in 9 quarters. The position peaked at $24.5M in Q4 2015. 228 funds tracked by Wall St. Rank hold MDCO as of Q2 2019.

  • Point72 Asset Management reported no remaining Medicines Co position as of Q2 2019 after selling out during the quarter.
  • Point72 Asset Management sold 17,600 Medicines Co shares in Q2 2019, an estimated $492K.
  • Point72 Asset Management first reported a position in Medicines Co in Q4 2014 and held it in 9 quarters.
  • Point72 Asset Management's Medicines Co position peaked at $24.5M in Q4 2015.
  • 228 funds tracked by Wall St. Rank held Medicines Co as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.